Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-NPC1L1 Antibody (R2N12)

Catalog #:   RHK80201 Specific References (17) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: WB
Accession: Q9UHC9
Overview

Catalog No.

RHK80201

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

WB: 1:1000-1:2000

Target

NPC1L1, Niemann-Pick C1-like protein 1, NPC1-like intracellular cholesterol transporter 1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9UHC9

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2N12

Data Image
References

Lipids, lipid-lowering drugs and the risk of herpes zoster: a Mendelian randomization study., PMID:39755897

Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study., PMID:38760735

Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention., PMID:37486464

Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab., PMID:32368969

Hepatitis C virus infection and tight junction proteins: The ties that bind., PMID:32268133

Novel milk casein-derived peptides decrease cholesterol micellar solubility and cholesterol intestinal absorption in Caco-2 cells., PMID:32113776

From lipid locus to drug target through human genomics., PMID:29800275

Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter., PMID:28714405

PCSK9 targets important for lipid metabolism., PMID:28176216

Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice., PMID:27923447

Targeting Viral Entry for Treatment of Hepatitis B and C Virus Infections., PMID:27617925

Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach., PMID:25833046

Resistance and intolerance to statins., PMID:24996502

Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor., PMID:22231557

Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann-Pick C1-like 1., PMID:18641187

Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe., PMID:16177187

Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein., PMID:15777641

Datasheet

Document Download

Anti-NPC1L1 Antibody (R2N12).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-NPC1L1 Antibody (R2N12) [RHK80201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only